Increased Interaction between B Cells and CD3+ T Cells in Nonprogressors with Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.

IF 10.2 1区 医学 Q1 ONCOLOGY Clinical Cancer Research Pub Date : 2025-05-01 DOI:10.1158/1078-0432.CCR-24-2425
Kathleen R Bartemes, Raymond M Moore, Brenna C Novotny, Kevin D Pavelko, Will A Sherman, Michael Rivera, Joaquin J Garcia, Linda X Yin, Daniel J Ma, Eric J Moore, Kathryn M Van Abel, David M Routman
{"title":"Increased Interaction between B Cells and CD3+ T Cells in Nonprogressors with Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.","authors":"Kathleen R Bartemes, Raymond M Moore, Brenna C Novotny, Kevin D Pavelko, Will A Sherman, Michael Rivera, Joaquin J Garcia, Linda X Yin, Daniel J Ma, Eric J Moore, Kathryn M Van Abel, David M Routman","doi":"10.1158/1078-0432.CCR-24-2425","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Tumor-infiltrating lymphocytes are associated with a decreased risk of recurrence in human papillomavirus-associated oropharyngeal squamous cell carcinoma. The composition and spatial distribution of tumor-infiltrating lymphocytes and tumor-infiltrating immune cells are not well characterized.</p><p><strong>Experimental design: </strong>Formalin-fixed, paraffin-embedded primary and lymph node (LN) tumor tissues from 10 progressors (cases) and 10 matched nonprogressors (controls) were interrogated by imaging mass cytometry. Immune, stromal, and tumor cells were quantified from selected regions of interest using machine learning. Nearest neighbors, cell-cell interactions, and niche analyses were performed.</p><p><strong>Results: </strong>In primary regions of interest, immune cell, lymphocyte, T cell, CD8+ T cell, and innate cell prevalence was significantly greater in controls. High prevalence of immune cells, lymphocytes, innate cells, and CD4+ T cells in primary tissues was significantly associated with increased time to event (TTE). Although primary and LN prevalence of T cells, CD4+ T cells, CD8+ T cells, macrophages, and tumor cells were significantly correlated, differences in LNs were neither significant nor associated with TTE. Average distances between T cells and the nearest B cells and between lymphocytes and the nearest tumor cells were decreased in control primary tissues. Interactions between B and T cells were less organized in primary tissues from cases. A niche predominantly comprising lymphocytes was associated with longer TTE.</p><p><strong>Conclusions: </strong>In human papillomavirus-associated oropharyngeal squamous cell carcinoma, immune cell subset prevalence in primary tumors differs with outcome and is associated with TTE. Interactions between B cells and both T-cell subsets are associated with longer TTE, underscoring the importance of active intratumoral immune responses in outcomes.</p>","PeriodicalId":10279,"journal":{"name":"Clinical Cancer Research","volume":" ","pages":"1719-1729"},"PeriodicalIF":10.2000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Cancer Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1158/1078-0432.CCR-24-2425","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Tumor-infiltrating lymphocytes are associated with a decreased risk of recurrence in human papillomavirus-associated oropharyngeal squamous cell carcinoma. The composition and spatial distribution of tumor-infiltrating lymphocytes and tumor-infiltrating immune cells are not well characterized.

Experimental design: Formalin-fixed, paraffin-embedded primary and lymph node (LN) tumor tissues from 10 progressors (cases) and 10 matched nonprogressors (controls) were interrogated by imaging mass cytometry. Immune, stromal, and tumor cells were quantified from selected regions of interest using machine learning. Nearest neighbors, cell-cell interactions, and niche analyses were performed.

Results: In primary regions of interest, immune cell, lymphocyte, T cell, CD8+ T cell, and innate cell prevalence was significantly greater in controls. High prevalence of immune cells, lymphocytes, innate cells, and CD4+ T cells in primary tissues was significantly associated with increased time to event (TTE). Although primary and LN prevalence of T cells, CD4+ T cells, CD8+ T cells, macrophages, and tumor cells were significantly correlated, differences in LNs were neither significant nor associated with TTE. Average distances between T cells and the nearest B cells and between lymphocytes and the nearest tumor cells were decreased in control primary tissues. Interactions between B and T cells were less organized in primary tissues from cases. A niche predominantly comprising lymphocytes was associated with longer TTE.

Conclusions: In human papillomavirus-associated oropharyngeal squamous cell carcinoma, immune cell subset prevalence in primary tumors differs with outcome and is associated with TTE. Interactions between B cells and both T-cell subsets are associated with longer TTE, underscoring the importance of active intratumoral immune responses in outcomes.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
B细胞和CD3+ T细胞在未进展的人乳头瘤病毒相关口咽鳞状细胞癌中增加相互作用
背景:肿瘤浸润淋巴细胞(til)与人乳头瘤病毒相关口咽鳞状细胞癌(HPV(+)OPSCC)复发风险降低相关。TILs和肿瘤浸润性免疫细胞的组成和空间分布尚不清楚。方法:采用影像细胞术对10例进展者(病例)和10例匹配的非进展者(对照)经福尔马林固定石蜡包埋的原发性和淋巴结(LN)肿瘤组织进行检测。使用机器学习从选定的感兴趣区域(roi)对免疫细胞、基质细胞和肿瘤细胞进行量化。进行了最近邻、细胞-细胞相互作用和生态位分析。结果:在原发性roi中,免疫细胞、淋巴细胞、T细胞、CD8+ T细胞和先天细胞的患病率明显高于对照组。原发组织中免疫细胞、淋巴细胞、先天细胞和CD4+ T细胞的高流行率与事件发生时间(TTE)的增加显著相关。虽然T细胞、CD4+ T细胞、CD8+ T细胞、巨噬细胞和肿瘤细胞的原发和LN患病率显著相关,但LN的差异并不显著,也与TTE无关。在对照原代组织中,T细胞与最近的B细胞、淋巴细胞与最近的肿瘤细胞之间的平均距离减小。在原代组织中,B细胞和T细胞之间的相互作用较少。主要由淋巴细胞组成的生态位与较长的TTE相关。结论:在HPV(+)OPSCC中,原发肿瘤的免疫细胞亚群患病率随预后不同而不同,并与TTE相关。B细胞和两种T细胞亚群之间的相互作用与更长的TTE相关,强调了活跃的肿瘤内免疫反应在结果中的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Cancer Research
Clinical Cancer Research 医学-肿瘤学
CiteScore
20.10
自引率
1.70%
发文量
1207
审稿时长
2.1 months
期刊介绍: Clinical Cancer Research is a journal focusing on groundbreaking research in cancer, specifically in the areas where the laboratory and the clinic intersect. Our primary interest lies in clinical trials that investigate novel treatments, accompanied by research on pharmacology, molecular alterations, and biomarkers that can predict response or resistance to these treatments. Furthermore, we prioritize laboratory and animal studies that explore new drugs and targeted agents with the potential to advance to clinical trials. We also encourage research on targetable mechanisms of cancer development, progression, and metastasis.
期刊最新文献
First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction using three independent cohorts. AL2846, a novel multi-kinase inhibitor, for previously treated radioiodine-refractory differentiated thyroid cancer: Exploratory clinical results from the phase Ib study. Post-Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in HER2-Expressing Solid Tumors. Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib - Results from the RET-MAP Registry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1